WASHINGTON: Anti-viral drug remdesivir cuts recovery times in coronavirus patients, according to the full results of a trial published on Friday night, three weeks after America’s top infectious diseases expert said the study showed the medication has "clear-cut" benefits.
Complete results from the research, which was carried out by US government agency the National Institute of Allergy and Infectious Diseases (NIAID), were published by leading medical periodical the New England Journal of Medicine.
The United States authorized the emergency use of remdesivir in hospitals on May 1, followed by Japan, while Europe is considering following suit.
Trump, 77, is charged with 34 counts of falsifying business records
Garcetti said a criminal case and indictment had been brought “and if there is any connection to state actors in...
Tehran has always said it had no plans to obtain nuclear weapons
“Both sides have been working together to ensure continued operation of Indian aviation platforms,” India’s...
“China is one of the pillars of the new world order,” Orban said
“We are putting maximum pressure on our partners to increase weapon deliveries,” Zelensky said
